Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 28085-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- NPC1L1 antibody
- Antibody type
- Polyclonal
- Description
- NPC1L1 antibody (Cat. #28085-1-AP) is a rabbit polyclonal antibody that shows reactivity with Human and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references NPC1L1, stabilized by PABPC1/IGF2BP1, accelerates atherosclerosis by enhancing CYP11A1-mediated mitophagy and ferroptosis.
Efficient Hydrolysis of Earthworm Protein and the Lipid-Lowering Mechanism of Peptides in the Hydrolysate.
Identification of targets and comparative study of administration methods for the lipid-lowering effects of fucoidan from Saccharina japonica.
Co-Expression of Niemann-Pick Type C1-Like1 (NPC1L1) with ACE2 Receptor Synergistically Enhances SARS-CoV-2 Entry and Fusion.
Zhang G, Song B, Huang X, Shi J
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2026 Apr 1;75(1)
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2026 Apr 1;75(1)
Efficient Hydrolysis of Earthworm Protein and the Lipid-Lowering Mechanism of Peptides in the Hydrolysate.
Zhang M, Mai X, Yang S, Huang Y, Zhang L, Ren W, Bai W, Xin X, Zhao W, Hao L
Foods (Basel, Switzerland) 2025 Jul 1;14(13)
Foods (Basel, Switzerland) 2025 Jul 1;14(13)
Identification of targets and comparative study of administration methods for the lipid-lowering effects of fucoidan from Saccharina japonica.
Chen P, Hao L, Li Q, Wang H, Chen H, Zhang M, Jia A, Jiang H, Dai H, Zhang R
International journal of biological macromolecules 2025 Feb;290:139102
International journal of biological macromolecules 2025 Feb;290:139102
Co-Expression of Niemann-Pick Type C1-Like1 (NPC1L1) with ACE2 Receptor Synergistically Enhances SARS-CoV-2 Entry and Fusion.
Elste J, Cast N, Udawatte S, Adhikari K, Payen SH, Verma SC, Shukla D, Swanson-Mungerson M, Tiwari V
Biomedicines 2024 Apr 8;12(4)
Biomedicines 2024 Apr 8;12(4)
No comments: Submit comment
No validations: Submit validation data